Castle Biosciences, Inc. · NASDAQ:CSTL

Juvenal Tobin W sold 1,730 Castle Biosciences, Inc. shares (Form 4)

Traded Aug 31, 2026 · Filed Sep 2, 2026

On Aug 31, 2026, Juvenal Tobin W (Chief Commercial Officer) sold 1,730 Castle Biosciences, Inc. shares at US$32.81 for US$56,761 under a trading plan, leaving 65,184 shares. Filed Sep 2, 2026 (Form 4).

Sold
1,730 shares
Price
US$32.81
Value
US$56,761
Holding after
65,184 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Commercial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 31, 2026Common StockSale1,730US$32.8165,184Direct

Source

View original at SEC

Related